Bristol Myers Squibb (BMY) Profit After Tax Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PAT Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
168.07% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-52.40% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
-45.93% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-183.48% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
5.14% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
53.69% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-8.70% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
8.77% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
8.77% |
| Dec 31, 2025 |
1,677.05% |
| Sep 30, 2025 |
81.15% |
| Jun 30, 2025 |
-99.88% |
| Mar 31, 2025 |
120.67% |
| Dec 31, 2024 |
-96.54% |
| Sep 30, 2024 |
-37.18% |
| Jun 30, 2024 |
41,900.00% |
| Mar 31, 2024 |
-238,320.00% |
| Dec 31, 2023 |
-13.63% |
| Sep 30, 2023 |
20.27% |
| Jun 30, 2023 |
-99.72% |
| Mar 31, 2023 |
0.00% |
| Dec 31, 2022 |
-14.72% |
| Sep 30, 2022 |
4.01% |
| Jun 30, 2022 |
34.69% |
| Mar 31, 2022 |
-99.75% |
| Dec 31, 2021 |
123.86% |
| Sep 30, 2021 |
-17.68% |
| Jun 30, 2021 |
1,341.18% |
| Mar 31, 2021 |
360.77% |
| Dec 31, 2020 |
-849.53% |
| Sep 30, 2020 |
37.48% |
| Jun 30, 2020 |
-105.94% |
| Mar 31, 2020 |
-145.19% |
| Dec 31, 2019 |
-191.19% |
| Sep 30, 2019 |
-28.14% |
| Jun 30, 2019 |
274.87% |
| Mar 31, 2019 |
15.41% |
| Dec 31, 2018 |
149.72% |
| Sep 30, 2018 |
124.97% |
| Jun 30, 2018 |
-58.30% |
| Mar 31, 2018 |
-2.62% |
| Dec 31, 2017 |
-359.35% |
| Sep 30, 2017 |
-30.45% |
| Jun 30, 2017 |
-21.44% |
| Mar 31, 2017 |
27.70% |
| Dec 31, 2016 |
555.84% |
| Sep 30, 2016 |
66.44% |
| Jun 30, 2016 |
996.92% |
| Mar 31, 2016 |
-0.33% |
| Dec 31, 2015 |
-829.63% |
| Sep 30, 2015 |
-0.27% |
| Jun 30, 2015 |
-138.92% |
| Mar 31, 2015 |
27.96% |
| Dec 31, 2014 |
-96.28% |
| Sep 30, 2014 |
5.78% |
| Jun 30, 2014 |
-37.69% |
| Mar 31, 2014 |
50.40% |
| Dec 31, 2013 |
-21.43% |
| Sep 30, 2013 |
197.33% |
| Jun 30, 2013 |
-16.90% |
| Mar 31, 2013 |
-43.42% |
| Dec 31, 2012 |
8.45% |
| Sep 30, 2012 |
-173.37% |
| Jun 30, 2012 |
-50.65% |
| Mar 31, 2012 |
-19.46% |
| Dec 31, 2011 |
1.19% |
| Sep 30, 2011 |
-25.58% |
| Jun 30, 2011 |
3.08% |
| Mar 31, 2011 |
24.16% |
| Dec 31, 2010 |
-89.51% |
| Sep 30, 2010 |
8.59% |
| Jun 30, 2010 |
28.99% |
| Mar 31, 2010 |
19.67% |
